$624 Million is the total value of Bracebridge Capital, LLC's 13 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | ISHARES TRcall | $337,698,000 | +36.8% | 40,250 | -98.7% | 54.08% | -25.2% | |
| New | ISHARES TR | $142,630,000 | – | 17,000 | +100.0% | 22.84% | – | |
| New | ISHARES TRcall | $58,418,000 | – | 3,900 | +100.0% | 9.36% | – | |
| LIBERTY MEDIA CORPdeb | $35,507,000 | +3.9% | 47,700,000 | 0.0% | 5.69% | -43.2% | ||
| Sell | DISH NETWORK CORPORATIONnote | $16,514,000 | -12.6% | 17,800,000 | -12.3% | 2.64% | -52.2% | |
| DISH | Sell | DISH NETWORK CORPORATIONcl a | $10,144,000 | -21.6% | 349,431 | -6.8% | 1.62% | -57.2% |
| LIBERTY MEDIA CORPdeb | $6,958,000 | +4.0% | 9,500,000 | 0.0% | 1.11% | -43.1% | ||
| TEVA PHARMACEUTICAL FIN LLCdbcv | $5,335,000 | -1.3% | 5,500,000 | 0.0% | 0.85% | -46.1% | ||
| NLSN | NIELSEN HOLDINGS | $4,254,000 | -4.6% | 300,000 | 0.0% | 0.68% | -47.9% | |
| AMBC | AMBAC FINL GROUP INC | $2,545,000 | -10.8% | 199,300 | 0.0% | 0.41% | -51.2% | |
| AQST | AQUESTIVE THERAPEUTICS INC | $2,083,000 | 0.0% | 428,571 | 0.0% | 0.33% | -45.2% | |
| Sell | DINE BRANDS GLOBAL INCput | $1,638,000 | -70.1% | 300 | -99.8% | 0.26% | -83.7% | |
| CCO | CLEAR CHANNEL OUTDOOR HLDGS | $756,000 | -3.9% | 756,426 | 0.0% | 0.12% | -47.4% | |
| Exit | CHESAPEAKE ENERGY CORPnote | $0 | – | -23,475,000 | -100.0% | -0.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LIBERTY MEDIA CORP DEL | 16 | Q3 2023 | 10.0% |
| AMBAC FINL GROUP INC | 16 | Q3 2023 | 6.2% |
| AQUESTIVE THERAPEUTICS INC | 16 | Q3 2023 | 0.6% |
| CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 0.6% |
| DISH NETWORK CORPORATION | 11 | Q2 2022 | 5.5% |
| ISHARES TR | 10 | Q3 2023 | 65.7% |
| ISHARES TR | 10 | Q3 2023 | 72.3% |
| COMPUTE HEALTH ACQUISITIN CO | 10 | Q2 2023 | 0.6% |
| CHURCHILL CAPITAL CORP VII | 9 | Q1 2023 | 0.3% |
| CHURCHILL CAPITAL CORP VI | 9 | Q1 2023 | 0.1% |
View Bracebridge Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Quotient Ltd | February 22, 2023 | 62,030 | 0.3% |
| Clarus Therapeutics Holdings, Inc. | July 06, 2022 | 1,461,822 | 2.8% |
| PERNIX THERAPEUTICS HOLDINGS, INC.Sold out | May 26, 2016 | 0 | 0.0% |
View Bracebridge Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| SC 13G/A | 2024-02-08 |
| SC 13D/A | 2023-11-17 |
| 4 | 2023-11-16 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-08-25 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-08-04 |
| SC 13D | 2023-06-16 |
| SC 13G | 2023-06-15 |
View Bracebridge Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.